🇺🇸 US Stock Screener ← Switch market ⚡ HerAI

Molina Healthcare, Inc. MOH R3KPHARMA

Healthcare · Healthcare Plans · United States
https://www.molinahealthcare.com
Company Profile ↓
$196.30
+21.77% 1Y
Mkt Cap$10.25B
P/E1,226.88
P/B2.50
52W High$242.88
52W Low$122.65
Book Value$80.21
EPS (TTM)$0.16

Company Overview

Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates through Medicaid, Medicare, Marketplace, and Other segments. The company was founded in 1980 and is headquartered in Long Beach, California.

Why Investors Should Care

Consistent Profit Growth

Net profit has compounded at 15.4% per year over the last five years.

Steady Revenue Expansion

Revenue has grown at a 17.4% CAGR over the past five years.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $45.43B (+11.7% YoY); net profit $472.00M.
  • Trailing 12 Months Year-on-year growth — revenue -5.7%, earnings -75.3%.
  • 5-Year Trend Long-term compounding — revenue CAGR 17.4%, profit CAGR 15.4%.

Growth & Price Performance

Compounded Sales Growth

5 Years:17.42%
1 Year:-5.70%

Compounded Profit Growth

5 Years:15.41%
1 Year:-75.30%

Stock Price Performance

1 Year:+21.77%
6 Months:+34.42%
3 Months:-1.06%
1 Month:-0.08%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed
52-Week Range 61% of range
$122.65 $242.88
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMAAbove
  • RSI (14)42.90 · Neutral
Price Performance
1M-0.08%
3M-1.06%
6M+34.42%
1Y+21.77%
Valuation vs Sector

P/E of 1,226.88 is above the sector median of 24.83 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 17.4% over 5 years.
  • Profit CAGR of 15.4% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Trading at a high P/E of 1226.9.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
1,226.88
Industry PE
24.83
Forward P/E
20.14
PEG Ratio
0.94
Book Value
$80.21
Price to Book
2.50
P/S
0.25
EV/EBITDA
14.73
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
17.42%
Profit 5Y
15.41%
Revenue (YoY)
-5.70%
Earnings (YoY)
-75.30%

Profitability & Returns

ROCE
9.53%
ROE
-0.16%
ROA
1.16%
Profit Margin
-0.02%
Op Margin
1.40%
Gross Margin
8.43%
EPS (Latest Qtr)
$1.19
EPS (TTM)
$0.16

Balance Sheet & Liquidity

Debt/Equity
0.95
Quick Ratio
1.61
Current Ratio
1.68
Debt
$3.95B
Total Assets
$16.00B
Current Assets
$12.93B
Working Capital
$5.23B

Ownership

Promoter Holding
1.42%
Chg in Prom Hold
-
FII / Inst Holding
111.81%
Chg in FII Hold
0.22%

Financial Snapshot

Enterprise Value
$10.25B
Total Revenue (TTM)
$42.47B
EBITDA
$390.00M
Free Cash Flow
$700.25M
Operating Cash Flow
$365.00M
Shares Outstanding
52.20M
Gross Margin
8.43%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 MOH Molina Healthcare, Inc. R3KPHARMA 196.30 1,226.88 $10.25B 0.00% 9.53% -0.16% 17.42% 15.41%
2 LLY Eli Lilly and Company SPXR3KPHARMA 1,123.91 37.80 $1.00T 0.60% - 102.29% 7.20% 11.41%
3 JNJ Johnson & Johnson SPXR3KPHARMA 269.12 31.22 $648.55B 1.98% 14.88% 25.74% 2.43% 4.76%
4 ABBV AbbVie Inc. SPXR3KPHARMA 248.78 70.48 $439.62B 2.78% 10.47% -129.24% 1.75% -29.06%
5 MRK Merck & Co., Inc. SPXR3KPHARMA 148.46 118.77 $366.28B 2.31% - 6.96% 5.64% 10.01%
6 UNH UnitedHealth Group Incorporated SPXR3KPHARMA 400.84 25.74 $359.79B 2.47% 9.74% 14.15% 10.40% 5.43%
7 NVS Novartis AG PHARMA 137.70 20.80 $261.73B 3.36% 21.09% 30.35% 9.25% 26.22%
8 AZN AstraZeneca PLC NDXPHARMA 160.04 23.99 $248.20B 2.00% 15.97% 21.96% 9.82% 45.96%
9 TMO Thermo Fisher Scientific Inc. SPXR3KPHARMA 603.02 32.49 $222.97B 0.29% 8.14% 13.51% 8.81% 12.95%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026Jun 2026
Revenue 3.17B3.52B3.61B-4.34B4.36B4.55B4.53B4.90B5.00B5.03B4.95B4.65B4.88B4.70B4.66B4.12B4.19B4.24B4.27B4.55B4.62B5.02B6.52B6.80B7.04B7.77B8.05B7.93B8.15B8.33B8.55B9.93B9.88B10.34B11.15B11.43B11.48B10.80B10.87B
Gross Profit 351.00M389.00M374.00M-434.00M466.00M471.00M354.00M546.00M254.00M564.00M446.00M615.00M673.00M566.00M664.00M581.00M583.00M561.00M578.00M--------------------
Operating Income 82.00M116.00M113.00M76.00M89.00M105.00M118.00M-6.00M82.00M-287.00M-81.00M-222.00M342.00M295.00M-280.00M265.00M257.00M-274.00M424.00M289.00M335.00M273.00M221.00M372.00M361.00M335.00M455.00M443.00M359.00M426.00M434.00M467.00M433.00M373.00M137.00M83.00M145.00M
Net Income 28.00M39.00M46.00M30.00M24.00M33.00M42.00M-47.00M77.00M-230.00M-97.00M-262.00M107.00M202.00M197.00M201.00M198.00M196.00M175.00M168.00M178.00M276.00M185.00M228.00M185.00M143.00M258.00M248.00M230.00M321.00M309.00M245.00M301.00M301.00M326.00M298.00M255.00M79.00M14.00M60.00M
Diluted EPS 0.560.720.770.520.430.580.76-0.851.37-4.10-1.70-4.591.643.022.903.012.993.062.752.672.924.653.103.893.162.464.394.253.955.525.354.215.175.175.655.454.751.510.271.19

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 4.09B4.54B5.91B6.59B9.67B14.18B17.78B19.88B18.89B16.83B19.42B27.77B31.97B34.07B40.65B45.43B
Gross Profit ---843.00M1.00B1.53B1.73B1.81B2.52B2.30B2.48B-----
Operating Income 105.00M135.82M41.09M137.00M193.00M387.00M306.00M-555.00M1.13B1.04B1.08B1.02B1.17B1.57B1.71B781.00M
Net Income 54.97M20.82M9.79M53.00M62.00M143.00M52.00M-512.00M707.00M737.00M673.00M659.00M792.00M1.09B1.18B472.00M
Diluted EPS 1.320.450.211.131.292.580.92-9.0710.6111.4711.2311.2513.5518.7720.428.92

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --1.65B1.93B2.99B4.43B6.58B7.45B8.47B7.15B6.79B9.53B12.21B12.31B14.89B15.63B15.56B
Total Equity 542.74M719.06M755.07M782.31M892.94M1.01B1.56B1.65B1.34B1.65B1.96B2.10B2.63B2.96B4.21B4.50B4.07B
Cash & Equivalents 469.50M455.89M493.83M796.00M936.00M1.54B2.33B2.82B3.19B2.83B2.45B4.15B4.44B4.01B4.85B4.66B4.25B
Long Term Debt --216.93M261.78M737.00M690.00M1.16B975.00M1.32B1.02B1.24B2.13B2.17B2.18B2.18B2.92B3.77B
Total Liabilities --897.07M1.15B2.11B3.42B5.02B5.80B7.13B5.51B4.83B7.44B9.58B9.35B10.68B11.13B11.49B
Current Liabilities --601.83M828.04M1.29B2.17B3.82B4.57B5.56B4.25B3.27B4.96B7.05B6.86B8.17B7.90B7.37B

Cash Flows (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 161.40M225.40M347.78M190.00M1.06B1.12B673.00M804.00M-314.00M434.00M1.90B2.12B773.00M1.66B644.00M-535.00M
Investing Cash Flow -288.82M-236.93M-93.58M-543.00M-536.00M-1.42B-206.00M-1.06B1.14B-293.00M-400.00M-1.65B-790.00M-744.00M-464.00M312.00M
Financing Cash Flow 113.81M49.47M47.74M493.00M79.00M1.08B19.00M636.00M-1.19B-559.00M217.00M-183.00M-441.00M-58.00M-347.00M-170.00M
Capital Expenditure -----115.00M-132.00M-176.00M-86.00M-30.00M-57.00M-74.00M-77.00M-91.00M-84.00M-100.00M-101.00M
Free Cash Flow ----945.00M993.00M497.00M718.00M-344.00M377.00M1.82B2.04B682.00M1.58B544.00M-636.00M
Share Buybacks 07.00M3.00M53.00M00-0047.00M606.00M128.00M400.00M01.00B1.00B

Ratios (Annual)

Figures in %.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % ---12.8%10.3%10.8%9.7%9.1%13.3%13.7%12.8%-----
Operating Margin % 2.6%3.0%0.7%2.1%2.0%2.7%1.7%-2.8%6.0%6.2%5.6%3.7%3.7%4.6%4.2%1.7%
Net Margin % 1.3%0.5%0.2%0.8%0.6%1.0%0.3%-2.6%3.7%4.4%3.5%2.4%2.5%3.2%2.9%1.0%
ROE % 7.6%2.8%1.3%5.9%6.1%9.2%3.2%-38.3%42.9%37.6%32.1%25.1%26.7%25.9%26.2%11.6%
ROCE % -12.9%3.7%8.1%8.5%14.1%10.6%-19.0%38.9%29.7%23.6%19.8%21.5%23.4%22.1%9.5%

Shareholding Pattern

Insiders
1.42%
Institutions
111.81%
Public Float
113.42%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 12.59% 6.57M $1.32B
2 AQR Capital Management, LLC 6.82% 3.56M $714.93M
3 Vanguard Portfolio Management LLC 5.35% 2.79M $560.25M
4 Capital World Investors 4.91% 2.56M $514.61M
5 Lingotto Investment Management LLP 4.81% 2.51M $504.28M
6 Vanguard Capital Management LLC 4.51% 2.36M $472.91M
7 Victory Capital Management Inc. 3.79% 1.98M $397.69M
8 FMR, LLC 3.58% 1.87M $375.74M
9 State Street Corporation 3.36% 1.76M $352.48M
10 Dimensional Fund Advisors LP 2.67% 1.39M $279.77M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for MOH

Google News ue, 08 Sep 2026

Health Insurance Providers Stocks Q2 Recap: Benchmarking Molina Healthcare (NYSE:MOH) - finance.yahoo.com

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxOdVhWVl9Hb2FsNDR3NHUzUk5sX3ZPVW5lV0htR0cxcXY0ajVXZmNjOTdCV0s4c2hTLUlOSUhZNGc2dFJjLVUzSjB5OEw2eXdvbm9wRXhRMWp0VTRxVUlCa2FUUTNOMmFxRXFvUkdqY1ljcjZ5Y0cxT0ZucG0zcVVTOUZzTnk0RHUybHY4YW…

Google News Fri, 04 Sep 2026

Molina Healthcare (MOH) Stock Forecast and Price Target 2026 $MOH - marketbeat.com

<a href="https://news.google.com/rss/articles/CBMiYkFVX3lxTE9qNFZVUUthZmFQWXBRNW9Nd3lrUlRnSzl6X1FrMU9ldHd4ajEtYk5YS3JJYVVqMm1pdUJsUlo3TXVzNkJMSDc5eGtqWjlyUzNhZTAwSDR1T1FSRzZEQkFTS2xB?oc=5" target="_blank">Molina Healthcare (MOH) Stock Forec…

Google News Mon, 07 Sep 2026

Molina Healthcare Inc (MOH) Stock Analysis: Navigating a 4.14% Potential Upside Amidst Market Volatility - directorstalkinterviews.com

<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxOZlFyU3doQVBObEltOTU0RXZEUGdhb1VzYnJtb3RDelFORjhUOWJtNGVRRlJhV0o4RGRZMldMWWRBSndKYnowd0pEdHJkVTFaQ0g4UmZIU25DLWpRVTRrYzFSVFhkTzA3LUFhNEtoYWdwcml6WjRPRXJiRjlMTkNJZkYxZ0xURThJNmFfS0…

Google News Sat, 05 Sep 2026

Molina Healthcare (MOH) Could Be 4% Undervalued After Margin Focus Comes Into View - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxQS0U1bFNzS1Q5ODI5a2Y5S2c0Zmg0MVVyWnV2Z1E4Nll3bWhRY2VMSGd6WlhLX3M5cUtJVzd1S0NvUmNwTjlLWTEyQ3c2aFJLZ0RoQ0VOMGdzalN1WTlUdkZNT3Y1WGpZbzlSVXZTX3BybmJyazZMSzMxbE5ScWxoMElqeVlZQzUzRVRld2…

Google News hu, 03 Sep 2026

Exor-linked investors now hold Molina Healthcare (NYSE: MOH) stake - Stock Titan

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxPWGpSaTNhSXdoZjhBTWk5aDJPTU5kYnJsU0NiaFhqWUxOUlpWOHh0aVdGVnRndmI4bVhLM21vanJZMkVtN1YxamZhWnNwZXV0MDBqLXp4RmdtNE5pVzZpYjFVNFBoMDJTWUJGVXk0SklyNHJYdlJId3JVVGFRY2lFVE84VWdsTzktVHdkSG…

Google News Wed, 26 Aug 2026

MOLINA HEALTHCARE INC (MOH) Stock Chart - ChartMill

<a href="https://news.google.com/rss/articles/CBMiY0FVX3lxTE9ETHQ0aUxFRVh3SDhiLWRsTnFhbWRzcnNTaHZ6bk5vTkV3SS1SZmh0aWlKOXVlbGhqeUJBYURGdFhCYy1zbVNZWEhQMC1qYkM1azNxUllFUlFXbEN4elJCM3B1NA?oc=5" target="_blank">MOLINA HEALTHCARE INC (MOH) Stock…

MOH — Frequently Asked Questions

What is the current share price of Molina Healthcare, Inc. (MOH)?

As of 2026-09-19 21:16 PDT, Molina Healthcare, Inc. (MOH) trades at $196.30 on NYSE. Its 52-week range is $122.65 to $242.88.

What is the market capitalisation of MOH?

Molina Healthcare, Inc. (MOH) has a market capitalisation of $10.25B on NYSE.

What is the P/E ratio of MOH?

MOH trades at a trailing price-to-earnings (P/E) ratio of 1,226.88. The industry average P/E is 24.83. Its price-to-book (P/B) ratio is 2.50.

What is the return on equity (ROE) of MOH?

MOH has a return on equity (ROE) of -0.16%. Its return on capital employed (ROCE) is 9.53%.

Is MOH a good stock to buy?

This page provides a data-driven analysis of Molina Healthcare, Inc. (MOH), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space